Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.63 |
| ▸ | PPARG | P37231 | 5/20 | 0.63 |
| ▸ | F7 | P08709 | 4/20 | 0.63 |
| ▸ | F3 | P13726 | 4/20 | 0.63 |
| ▸ | PPARD | Q03181 | 4/20 | 0.63 |
| ▸ | PPARA | Q07869 | 4/20 | 0.63 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.63 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.63 |
| ▸ | FABP4 | P15090 | 2/20 | 0.63 |
| ▸ | HPGD | P15428 | 2/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.63 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.63 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6923085 | 1.00 | EPHX2 (0.69) | EPHX2ALDH1A1PPARGF7F3 | |
| SCHEMBL6293226 | 1.00 | EPHX2 (0.69) | EPHX2ALDH1A1PPARGF7F3 | |
| SCHEMBL7716340 | 0.98 | EPHX2 (0.71) | EPHX2ALDH1A1PPARGF7F3 | |
| SCHEMBL6928120 | 0.98 | EPHX2 (0.71) | EPHX2ALDH1A1PPARGF7F3 | |
| SCHEMBL1627821 | 0.92 | EPHX2 (0.71) | EPHX2PPARGF7F3PPARD | |
| SCHEMBL1602949 | 0.92 | EPHX2 (0.62) | EPHX2ALDH1A1PPARGF7F3 | |
| SCHEMBL1602954 | 0.92 | EPHX2 (0.62) | EPHX2ALDH1A1PPARGF7F3 | |
| SCHEMBL1627823 | 0.92 | EPHX2 (0.71) | EPHX2PPARGF7F3PPARD | |
| SCHEMBL1627678 | 0.92 | EPHX2 (0.71) | EPHX2PPARGF7F3PPARD | |
| SCHEMBL1627680 | 0.92 | EPHX2 (0.71) | EPHX2PPARGF7F3PPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050222253-A1 | Anti-cancer nitro- and thia-fatty acids | FERRANTE ANTONIO | 2005-10-06 | — | — | US | disclosed |
| US-20050176815-A1 | Anti-inflammatory nitro-and thia-fatty acids | FERRANTE ANTONIO (AU) | 2005-08-11 | — | — | US | disclosed |
| US-20050176817-A1 | Anti-inflammatory nitro- and thia- fatty acids | FERRANTE ANTONIO (AU) | 2005-08-11 | — | — | US | disclosed |
| US-20050176816-A1 | Anti-inflammatory nitro- and thia-fatty acids | FERRANTE ANTONIO (AU) | 2005-08-11 | — | — | US | disclosed |
| US-6924309-B2 | Anti-inflammatory nitro and thia-fatty acids | CHILDREN, YOUTH AND WOMEN'S HEALTH SERVICE INCORPORATED (AU) | 2005-08-02 | — | — | US | disclosed |
| EP-0904072-A4 | METHODS OF TREATING IMMUNOPATHOLOGIES USING POLYUNSATURATED FATTYACIDS | PEPTIDE TECHNOLOGY PTY LTD (AU) | 2003-07-30 | — | — | EP | disclosed |
| EP-1218000-A4 | ANTI-CANCER NITRO- AND THIA-FATTY ACIDS | WOMENS & CHILDRENS HOSPITAL (AU) | 2003-07-09 | — | — | EP | disclosed |
| EP-1218000-A1 | ANTI-CANCER NITRO- AND THIA-FATTY ACIDS | WOMEN'S AND CHILDREN'S HOSPITAL (AU) | 2002-07-03 | — | — | EP | disclosed |
| US-6376688-B1 | Modified polyunsaturated fatty acids | PEPTIDE TECHNOLOGY LIMITED (AU) | 2002-04-23 | — | — | US | disclosed |
| EP-0869941-B1 | MODIFIED POLYUNSATURATED FATTY ACIDS | PEPTECH LTD (AU) | 2001-12-12 | — | — | EP | disclosed |
| US-6262119-B1 | ADMINISTERING POLYUNSATURATED FATTY ACID CONTAINING 18-25 CARBONS, 1-6 DOUBLE BONDS AND HAS ONE OR TWO SUBSTITUTIONS FOR THERAPY OF T-CELL MEDIATED DISEASES SUCH AS DIABETES, MULTIPLE SCLEROSIS, RHEUMATOID ARTHRITIS, HERPES SIMPLEX ETC. | PEPTIDE TECHNOLOGY LIMITED (AU) | 2001-07-17 | — | — | US | disclosed |
| WO-2001021172-A1 | ANTI-CANCER NITRO- AND THIA-FATTY ACIDS | WOMEN'S AND CHILDREN'S HOSPITAL ADELAIDE (AU) | 2001-03-29 | — | — | WO | disclosed |
| EP-0904072-A1 | METHODS OF TREATING IMMUNOPATHOLOGIES USING POLYUNSATURATED FATTYACIDS | Peptide Technology Pty. Ltd. (AU) | 1999-03-31 | — | — | EP | disclosed |
| EP-0869941-A1 | MODIFIED POLYUNSATURATED FATTY ACIDS | PEPTIDE TECHNOLOGY LTD (AU) | 1998-10-14 | — | — | EP | disclosed |
| EP-0869941-A4 | — | — | 1998-10-14 | — | — | EP | disclosed |
| WO-1997038688-A1 | METHODS OF TREATING IMMUNOPATHOLOGIES USING POLYUNSATURATED FATTYACIDS | PEPTIDE TECHNOLOGY PTY. LIMITED (AU) | 1997-10-23 | — | — | WO | disclosed |
| WO-1996011908-A1 | MODIFIED POLYUNSATURATED FATTY ACIDS | PEPTIDE TECHNOLOGY LIMITED (AU) | 1996-04-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176815-A1 | Anti-inflammatory nitro-and thia-fatty acids | PTGES, PTGES2, ALOX5 | EPHX2 159/4885ALDH1A1 884/4885PPARG 80/4885 |
| US-20050222253-A1 | Anti-cancer nitro- and thia-fatty acids | ALOX5, ALOX15, ALOX12 | EPHX2 160/4885ALDH1A1 316/4885PPARG 92/4885 |
| US-20050176817-A1 | Anti-inflammatory nitro- and thia- fatty acids | PTGES, PTGES2, ALOX5 | EPHX2 159/4885ALDH1A1 884/4885PPARG 80/4885 |
| US-20050176816-A1 | Anti-inflammatory nitro- and thia-fatty acids | PTGES, PTGES2, ALOX5 | EPHX2 159/4885ALDH1A1 884/4885PPARG 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.